欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (5): 595-600.

• 综述与讲座 • 上一篇    

经皮冠状动脉介入治疗术中无复流现象防治研究进展

李晓倩, 柯永胜   

  1. 皖南医学院弋矶山医院心内科,芜湖 241001,安徽
  • 收稿日期:2011-03-14 修回日期:2011-03-21 发布日期:2011-07-08
  • 通讯作者: 柯永胜,男,主任医师,教授,硕士生导师,研究方向:冠心病介入治疗,心肌缺血再灌注机制研究。 E-mail:keyongsheng@163.com
  • 作者简介:李晓倩,女,在读硕士研究生,心血管内科专业。E-mail:lixiaoqian0427@163.com

Progression of no-reflow prevention and treatment in percutaneous coronary intervention

LI Xiao-qian, KE Yong-sheng   

  1. Department of Cardiology, Yijishan Hospital, Wannan Medical College, Wuhu 241001, Anhui, China
  • Received:2011-03-14 Revised:2011-03-21 Published:2011-07-08

摘要: 随着经皮冠状动脉介入治疗方法在临床上得到广泛应用,急性ST段抬高性心肌梗死直接经皮冠状动脉介入治疗(PCI)的比例越来越高。但急诊PCI过程中,常常发生无复流现象,严重影响患者的预后。本文就无复流的可能机制和处理作一简要介绍。

关键词: 经皮冠状动脉介入, 无复流, 慢血流, 血管扩张剂, 血小板糖蛋白受体拮抗剂, 血栓抽吸, 远端保护装置

Abstract: As percutaneous coronary intervention is widely used in clinic, more and more acute ST-segment elevation myocardial infarction patients undergo direct PCI. However, no-reflow phenomenon seriously affects the prognosis of patients during emergent PCI. The possible mechanisms and therapies of no-reflow phenomenon will be introduced briefly in this review.

Key words: Percutaneous coronary intervention, No-reflow, Slow reflow, Vasodilator agents, Platelet glycoprotein receptor antagonist, Thrombus aspiration, Distal protection equipment

中图分类号: